Fernando M. Rodrigues Sells 2,358 Shares of Teladoc Health, Inc. (NYSE:TDOC) Stock

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) insider Fernando M. Rodrigues sold 2,358 shares of Teladoc Health stock in a transaction that occurred on Monday, June 2nd. The shares were sold at an average price of $6.86, for a total transaction of $16,175.88. Following the sale, the insider now owns 4,174 shares in the company, valued at $28,633.64. This represents a 36.10% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Fernando M. Rodrigues also recently made the following trade(s):

• On Tuesday, June 3rd, Fernando M. Rodrigues sold 4,174 shares of Teladoc Health stock. The stock was sold at an average price of $6.91, for a total transaction of $28,842.34.

Teladoc Health Stock Performance

TDOC traded up $0.35 during trading on Friday, hitting $7.28. The stock had a trading volume of 5,275,426 shares, compared to its average volume of 6,288,824. The firm has a market cap of $1.28 billion, a price-to-earnings ratio of -1.26 and a beta of 1.82. Teladoc Health, Inc. has a one year low of $6.35 and a one year high of $15.21. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. The company has a 50 day moving average price of $7.15 and a 200-day moving average price of $9.13.

Institutional Trading of Teladoc Health

Several large investors have recently bought and sold shares of the business. Vanguard Group Inc. raised its position in Teladoc Health by 7.0% in the first quarter. Vanguard Group Inc. now owns 19,752,338 shares of the health services provider's stock valued at $157,229,000 after purchasing an additional 1,289,183 shares during the last quarter. Point72 Asset Management L.P. boosted its position in shares of Teladoc Health by 33.6% during the fourth quarter. Point72 Asset Management L.P. now owns 11,179,863 shares of the health services provider's stock valued at $101,625,000 after buying an additional 2,813,568 shares during the last quarter. Renaissance Technologies LLC boosted its position in Teladoc Health by 15.5% in the fourth quarter. Renaissance Technologies LLC now owns 5,674,542 shares of the health services provider's stock worth $51,582,000 after purchasing an additional 763,265 shares during the last quarter. Geode Capital Management LLC boosted its position in Teladoc Health by 0.6% in the fourth quarter. Geode Capital Management LLC now owns 3,947,831 shares of the health services provider's stock worth $35,894,000 after purchasing an additional 22,664 shares during the last quarter. Finally, Maple Rock Capital Partners Inc. raised its stake in shares of Teladoc Health by 189.5% in the fourth quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider's stock valued at $32,369,000 after buying an additional 2,331,000 shares during the period. 76.82% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms have weighed in on TDOC. Piper Sandler cut their target price on Teladoc Health from $13.00 to $12.00 and set an "overweight" rating for the company in a research report on Thursday, February 27th. Wells Fargo & Company reduced their target price on Teladoc Health from $10.00 to $8.00 and set an "equal weight" rating for the company in a report on Thursday, May 8th. Needham & Company LLC restated a "hold" rating on shares of Teladoc Health in a report on Thursday, May 1st. Evercore ISI reduced their price objective on Teladoc Health from $8.00 to $7.00 and set an "in-line" rating for the company in a research report on Thursday, May 1st. Finally, The Goldman Sachs Group reduced their price objective on Teladoc Health from $13.00 to $10.00 and set a "buy" rating for the company in a research report on Thursday, May 1st. Twelve investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $9.60.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.